% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

  • win2few win2few Oct 18, 2011 8:12 PM Flag

    Hmmm, so where is AMLN's P R ...

    dept ??? Evidently out to lunch ....guess they don't like sharing good news like the U K announcement. Of course, they didn't hesitate to announce that the maximum dose of Victoza lowered blood sugar readings more than a lower dose of Bydureon.... jeez, what a company .. Without the lizard, they would have been down the tube long ago ....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Bradbury speaks and the stock usually falls.
      Many here have long complained about the company's poor PR team.The dissemination of information in a positive(or negative)professionally introduced manner to the public is a D grade and is another reason why Amylin finds itself a 10 dollar stock.

    • I agree... besides highlighting failed Duration-6 results, Amylin also highlighted Metreleptin Antibody issue which stopped Phase II testing for obesity and they also announced the end of Pramlintide + Metreleptin Program as it exists today. I just don't understand the lack of postive news flow and the lack of transparency surrouding Amylin. I sometimes wonder if Amylin is complicit with certain major shareholders and hedge funds to manipulate the stock up and down, without interferance from Amylin. Amylin's news flow and PR initiatives have not exactly been shareholder friendly so far in 2011. Let's see what Dan delivers tomorrow or will we get more of the same B S.